Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Wilms Tumor 1Sarcoma 1Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lung Neoplasms 1Leukemia 1Kidney Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 23Paclitaxel 18Bevacizumab 16Radiotherapy 15Erlotinib Hydrochloride 13Cisplatin 9Gemcitabine 7Gefitinib 7Docetaxel 7Taxes 6Pemetrexed 6Cetuximab 4Etoposide 3Amplified Fragment Length Polymorphism Analysis 3pegfilgrastim 2Vinorelbine 2Topotecan 2Radiotherapy, Conformal 2Radiation 2Irinotecan 2Gene Expression Profiling 2Anterior Temporal Lobectomy 2vandetanib 1sargramostim 1romidepsin 1lentiviral minigene vaccine of COVID-19 coronavirus 1irofulven 1cositecan 1advexin 1Video-Assisted Surgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Adenocarcinoma, Bronchiolo-Alveolar × Glutamic Acid × Clear all
NCT01107626 2023-07-07

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
1,516 enrolled 12 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡